BRNS

Conviction 20HealthcareScan · Mon, Aug 10, 2026

BRNS$0.5922-1.14%

ResistanceSupportVol 14

Vol MA14 59.71K

May 11May 28Jun 16Jul 6Jul 23Aug 10

Barinthus Biotherapeutics plc.PHARMACEUTICAL PREPARATIONSwww.barinthusbio.com ↗

Price0.5922

Change-1.14%

Gap-1.14%

Rel volume8.10×

Avg volume56.15K

Avg $ vol33.2K

SMA 200.5934

SMA 500.6269

SMA 2000.6971

Price vs 50-5.54%

Price vs 200-15.04%

MA stackbearish

50/200 cross—

Supertrendup · 0.4949

RSI (14)48

MACD hist0.00

MACD crossbull · 1d

Stoch %K / %D65 / 45

ADX (14)9

+DI / −DI15 / 20

RSI divergence—

MACD divergence—

ATR %+7.54%

ADR %6.79%

52w high1.58

52w low0.0000

From 52w high-62.57%

Above 52w low—

New 52w highNo

SqueezeOn · 26d

Bollinger width20.29%

%B0.49

Donchian pos34.82%

Donchian high0.6899

Donchian low0.5400

AVWAP (52w high)0.7629

vs AVWAP high-22.38%

AVWAP (52w low)0.6601

vs AVWAP low-10.29%

OBV trendDown

Chaikin MF (20)-0.33

Today vs 20d8.10×

Avg vol (14d)59.71K

Avg vol (20d)56.15K

Avg $ vol (20d)33.2K

Market cap24.19M

RS 3m (vs SPY)-16.29%

RS 6m (vs SPY)-33.45%

RS line new highNo

Trend template0/8

Technical rank22.3

1 week-1.28%

1 month-7.15%

3 months-11.61%

6 months-16.00%

1 year-59.16%

YTD-19.43%

P/E-0.36

P/B0.42

P/S—

P/FCF-0.50

EPS-1.64

Div yield—

ROE-116.39%

ROA-81.12%

Debt/Eq0.00

Current5.54

EV/EBITDA0.54

Gross margin—

Net margin—

Rev growth-100.00%

EPS growth-8.77%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value-34.95M

Revenue0

Net income-10.58M

Gross profit—

Free cash flow-48.02M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out40.85M

Employees14

ListedFri, Apr 30, 2021

Free float23.13M

Float %56.6%

Short interest29.44K

Days to cover0.5d

Short volume43.1%

Squeeze score20 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction20 / 100

Pattern quality—

Tech rank22.3 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance0.7422

Support0.5477

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in BRNS

All disclosures →

No recent disclosed trades by Congress in BRNS. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in BRNS

No recent insider (Form 4) filings in BRNS. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in BRNS · 4 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.